RBMS1 and hepatocellular carcinoma: Luciferase reporter assays showed that miR-19b-3p inhibitor obviously elevated luciferase activity of RBMS1-WT reporter vector but not in the RBMS1-MUT reporter vector in HCC cells (Figure 4f).